Chapter 1849 Something seems to have happened

Pi Yangyang stretched out his hand and shook his hand, saying, "If Mr. Stotchi is interested in Xiaoye Pharmaceutical, we can talk about it."

After listening to the translation, a trace of disdain flashed across Stotchi's expression. "Originally, I was interested in Ono Pharmaceutical, but now the 'Sanhe Xuekang' developed by the Sanhe Group seems to be better than 'Ono Xuekang'. So I'm sorry, I have decided to cooperate with the Sanhe Group."

Pi Yangyang curled his lips and said calmly: "Well, I wish you a successful cooperation."

Stotch nodded and turned to leave.

It can be seen that he was still obsessed with Xiaoye Pharmaceutical. But after he knew that Xiaoye Pharmaceutical was controlled by a Chinese company, he seemed to lose interest immediately.

Pi Yangyang didn't say much.

Even if he really wanted to market his product in Europe, he couldn't lower his status and ask for help.

He believes that Western financial groups are more pragmatic when it comes to real interests.

As long as you have good products, they will definitely put aside their arrogance and come to you for cooperation.

At this time, the conference host has already come on stage.

She briefly introduced the main content of today's discussion meeting, and then invited the reviewers to come on stage.

Today's discussion meeting was actually initiated by the Sanhe Foundation.

This was mainly because the last time the Sanhe Group lost the lawsuit, the impact was huge, causing their group’s stock price to fluctuate, and the market value of more than 60 billion US dollars evaporated in just one week.

This time they produced a new blood product, and it achieved very good results in clinical trials.

Therefore, Hirota Kazu felt that it was time to restore the reputation of the Sanhe Group.

Today's discussion meeting is actually his attempt to use the media and relevant departments to suppress Ono Pharmaceutical's Xuekang and completely squeeze Ono Pharmaceutical out of the market.

He put in a lot of effort, spent a lot of effort and spent a lot of money for this seminar.

However, he is sure that after today's discussion meeting, Ono Pharmaceutical's Xuekang will be completely replaced by "Sanhe Xuekang".

In addition, Sanhe Group will also reach a strategic cooperation with Grey Group, the largest medicinal materials sales group in Europe.

This is also his greatest achievement since he took over as president of the Sanhe Group.

After all, many veterans in the consortium were dissatisfied with Hirota's resignation, thinking that Hirota was mediocre and that if he were to manage the consortium, he might not be able to catch up with Hirota.

So Hirota Kazu wants to prove to them who is truly more capable.

The first judge to come on stage was Yuta Ito, director of the Edo Pharmaceutical Agency, followed by Lu Lamo, an expert from country E, Lakuri, an expert from country U, Daisuke Ito, president of the J country's Medical Association, and Iori Takeshi Yamaguchi, a master of Chinese herbal medicine, a total of five people.

Seeing Yamaguchi Ioritake coming on stage, Pi Yangyang couldn't help but laugh.

In fact, this old man's medical skills are quite good. If he hadn't met Pi Yangyang, the last exchange meeting wouldn't have been so embarrassing.

Yamaguchi Ioritake obviously didn't see Pi Yangyang. He sat down with an arrogant look on his face, picked up the teacup and drank tea slowly.

After all five review members came on stage, the host announced that the discussion meeting officially began.

First, the Sanhe Foundation provided review materials and went on stage to talk about the research and development process of "Sanhe Xuekang" and the results of clinical trials.

A staff member of the Sanhe Group came up to the stage with a stack of printed materials and distributed them to the five people on the stage.

Then he came to the podium and began his passionate speech.

The images on the screen on the stage kept changing according to the content of his speech.

Jiazi was translating on the side. When Pi Yangyang heard the person on the stage say that "Sanhe Xuekang" was developed by their company's more than one hundred doctoral-level researchers over a period of three years, day and night.

After thousands of revisions, the formula was finally finalized and put into the production trial stage, and it has achieved great success so far. He couldn't help but be stunned.

Not only was he stunned, but Kako, Suzuki Yuta, and Nagakawa Shun also looked stunned.

"Oh my god, are you so shameless?"

Pi Yangyang couldn't help but swear.

This is just a bunch of nonsense, and I am so moved by it.

Jiazi couldn't help but say, "It's quite shameless!"

Reporters on the field were filming and reporting on the scene.

During the speech, there was constant applause, and the five judges on the stage kept nodding their heads in approval.

"After a week of clinical trials, with the voluntary cooperation of more than 100 patients, we have made an accurate assessment of the efficacy of 'Sanhe Xuekang'. According to the data, the condition of all patients was greatly controlled and reversed after taking 'Sanhe Xuekang'. Some seriously ill patients have even recovered and can take care of themselves..."

The speech continued with great passion.

"Compared with similar products, 'Sanhe Xuekang' has the characteristics of fast onset, obvious effect, safety and reliability. Its appearance will be good news for the majority of blood disease patients and is expected to completely save leukemia patients from despair!"

At this point, there was thunderous applause.

Hirota Kazu was very satisfied and he clapped and nodded vigorously.

At the same time, he turned his head and glanced at Pi Yangyang, his expression clearly revealing a hint of pride.

"Next, please ask the Ono Pharmaceutical representative to provide the demonstration materials and explain the product."

the host shouted after the speaker from Sanhe Pharmaceutical stepped down from the stage.

Yuta Suzuki stood up, took a deep breath, and walked steadily onto the stage holding the documents.

Hirota Kazu, Ito Sa, Segawa Yui and others stared at him closely, their eyes full of disdain.

Not to mention that "Sanhe Xuekang" has a much better reputation than "Ono Xuekang" in hospital trials. Even if it is not as good as "Ono Xuekang", Hirota Kazu is confident that he can win this discussion meeting.

After all, he spent a lot of money on this seminar.

Among the five people on the stage, except Yamaguchi Ioritake, the other four have benefited a lot.

Unfortunately, although Yamaguchi Ioritake was greedy for money, he sneered at this kind of bribery, so Hirota Kazuya did not dare to go to him easily.

But it doesn't matter, he is sure that he will win the argument today.

At that time, he only needs to control the media to put Ono Pharmaceutical into an irretrievable situation.

When he thought of his pride, he couldn't help but sneer, looking at Suzuki Yuta who was walking in front of him, and said with a bit of sarcasm: "President Suzuki, I think you should not waste your energy."

Suzuki Yuta just glanced at him indifferently, said nothing, walked quickly onto the stage and handed the information to the five judges.

Then, he also began to introduce the research and development history of "Xiaoye Xuekang", as well as the previous achievements, and the current results obtained in hospital trials after improvements.

Although there was applause, it was obviously much weaker than the applause at the beginning.

Several people on the stage listened to his speech while looking through the materials and shaking their heads from time to time.

Obviously, they are not very satisfied with the clinical trial results of "Xiaoye Xuekang".

Because there were only more than 30 volunteers participating in the clinical trial of "Xiaoye Xuekang".

Although it has met the minimum requirements, it is still less than one-third of the volunteers of "Sanhe Xuekang".

"President Suzuki, the number of people in your clinical trial is a bit small!"

After Suzuki Yuta finished his speech, the Director of the Drug Administration, Ito Yuta, spoke slowly.

Suzuki Yuta replied: "Mr. Ito, according to the minimum number of people required, our test number has met the requirement."

Ito Daisuke said solemnly, "It has met the minimum requirements, but medicines are not something else. They are related to the health and even life and death of every patient. Therefore, both your manufacturers and our regulatory authorities must be rigorous. President Suzuki, with such data, how do you want to convince our jury?"

Lulamo and Lacuri were also talking, spreading their hands and shaking their heads slightly from time to time.

Then Lacuri spoke and also expressed that he was not very satisfied with the test results of "Ono Xuekang".

Yamaguchi Ioritake, who had been silent the whole time, frowned and said slowly: "Everyone, there is no need to deny it so quickly. Ono Pharmaceutical is a long-established pharmaceutical company, and the Chinese patent medicines they produce have always been well-received. This trial may not be satisfactory, but the results are still good. All volunteers' conditions have been alleviated, and no adverse reactions have occurred. So I think 'Ono Xuekang' also meets the requirements for listing."

After listening to Jiazi's translation, Pi Yangyang was surprised again.

Unexpectedly, this old wall-dong actually has some principles.

"Okay, both companies have finished their presentations. Now let the jury make the final vote to determine who will be the final winner!"

Ito Yuta knocked on the table and spoke in an official tone.

"Of course Sanhe Xuekang wins. Is there any need to discuss this?"

Ito Sa in the audience shouted, and immediately attracted many people to agree with him.

The scene was suddenly in chaos, and at this moment, Hirota Kazu's secretary suddenly raised his phone nervously and said to him, "President Hirota, it's a call from President Kameda. It seems...something happened..."